You are here

  • Home
  • Archive
  • Volume 22, Issue 1
  • Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients

Article info

Article menu

Download PDFPDF

Original article
Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients
Free

Authors

  1. Correspondence to Dr Francesco Cattel, AOU S. Giovanni Battista Hospital, Cap 10126 C.so Bramante, 88/90 Torino, Turin, Italy; Fcattel{at}gmail.com
View Full Text

Citation

Cattel F, Ancona F, Chiumente M, et al
Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients
European Journal of Hospital Pharmacy 2015;22:12-17.

Publication history

  • Received October 8, 2013
  • Revised March 15, 2014
  • Accepted May 22, 2014
  • First published June 5, 2014.
Online issue publication 
May 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions